Philip Steriti

Role: OXB
Location: Boston, MA, US
LinkedIn followers: 500 followers

OtherView LinkedIn profile

About Philip Steriti

Philip J. Steriti p•••••@gmail.com I’m a Facilities Maintenance…

Experience

OXB
Present

Education

Benjamin Franklin Institute Of Technology
Associate, Associate of Applied Science - Automotive Technology
1990 — 1992

Skills

Steam
Management
Boilers
Facilities Management
Project Management
Biotechnology
Process Engineering
Teamwork
Valves
Software Documentation
Maintenance & Repair
Pumps
21 Cfr Part 11
Instrumentation
Construction
Research
Process Improvement
Gas
Preventive Maintenance
Hvac
Pressure Vessels
Water Treatment
Calibration
Capa
Sap
R&D
Continuous Improvement
Validation
Metal Fabrication
Piping
Welding
Manufacturing
Inspection
Automation
Pharmaceutical Industry
Sop
Maintenance Management
Change Control
Gmp
Water

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@oxb.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

OXB

Pharmaceutical Manufacturing · 939 employees

OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, OXB has over 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB’s world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVecta™ system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines. OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US. Learn more at www.oxb.com and follow us on LinkedIn and YouTube.

oxb.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Philip Steriti

Experience

Education

Benjamin Franklin Institute Of Technology

Skills

Find verified contacts for anyone on LinkedIn